The position of neoadjuvant chemotherapy in the treatment of non-small-cell lung carcinoma;Postavení neoadjuvantní chemoterapie v léč bě nemalobuněčného plicního karcinomu

Vnitrni Lekarstvi

Volumn 53, Issue 6, 2007, Pages 715-723

  Špásová, Irena ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Adjuvant chemotherapy of NSCLC; Induction chemotherapy of NSSCLC; Neoadjuvant chemotherapy of NSCLC; Non small cell lung carcinoma; NSCLC; Surgical treatment of NSCLC

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; MITOMYCIN; NAVELBINE; PACLITAXEL; VINBLASTINE; VINDESINE;

ADJUVANT CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SURGERY; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOADJUVANT THERAPY;

EID: 34347238556     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89(Suppl 4): 225-233.
2. Bunn PA jr. Future directions in clinical research for lung cancer. Chest 1994; 106: 399S-407S.
3. Pantel K, Izbicki J, Passlick B et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without over metastases. Lancet 1996; 347: 649-653.
4. Bulzebruck H, Bopp R, Drings P et al. New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification. Cancer 1992; 70: 1102-1110.
5. Non-Smal Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: Meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995; 311: 899-909.
6. Splinter TA. Chemotherapy in advanced non-small cell lung cancer. Eur J Cancer 1990; 26: 1093-1099.
7. Souquet PJ, Chauvin F, Boissel JP et al. Polychemotherapy in advanced non small cell lung cancer. Lancet 1993; 342: 19-21.
8. Bunn PA jr, Kelly K. New chemoterapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions. Clin Cancer Res 1998; 4: 1097-1100.
9. Ohgami A, Mitsudomi T, Sugio K et al. Micrometastatic tumor cells in the bone marrow of patients with completely resected non-small-cell lung cancer. Ann Thorac Surg 1997; 64: 363-367.
10. D'Cunha J, Corfits AL, Herndon JE 2nd et al. Molecular staging of lung cancer: realtime polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer - preliminary results of Cancer and Leukemia Group B trial 9761. J Thorac Cardiovasc Surg 2002; 123: 484-491.
11. Kurusu Z, Yamashita J, Ogawa M et al. Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small cell lung cancer. Surgery 1999; 126: 820-826.
12. Pisters KMW, Ginsberg RJ, Giroux DJ et al. Induction chemotherapy before surgery for early-stage lung cancer: A novel aproach. Bimodality Lung Oncology Team. J Thorac Cardiovasc Surg 2000; 119: 429-439.
13. Eberhardt WE, Albain KS, Pass H et al. Induction treatment before surgery for non-small cell lung cancer. Lung Cancer 2003; 42(Suppl 1): S9-S14.
14. Ginsberg RJ. Neoadjuvant (induction) treatment for non-small cell lung cancer. Lung Cancer 1995; 12(Suppl 1): S33-S40.
15. Rusch VW, Albain KS, Crowley JJ et al. Neoadjuvant therapy: a novel and effective treatment for stage 1Mb non-small cell lung cancer. Ann Thorac Surg 1994; 58: 290-295.
16. Depierre A, Milleron B, Moro-Sibilot D et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 2002; 20: 247-253.
17. Gralla RJ, Kris MG, Burke MT et al. The influence of the addition of mitomycin to vindesine plus cisplatin in a random-assignment trial in 120 patients with non-small cell lung cancer. Proc Am Soc Clin Oncol 1986; 5: A182.
18. Martini N, Kris MG, Gralla RJ et al. The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0). Ann Thorac Surg 1988; 45: 370-379.
19. Rosell R, Maestre A, Font A et al. A randomized trial of Mitomycin/Ifosfamide/Cisplatin chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung. Semin Oncol 1994; 21: 28-33.
20. Roth JA, Fossella F, Komaki R et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994; 86: 673-680.
21. Rosell R, Gómez-Codina J, Camps C et al. Preresectional chemotherapy in stage IIIA non-small cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 1999; 26: 7-14.
22. Roth JA, Atkinson EN, Fossella F et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. Lung Cancer 1998; 21: 1-6.
23. Elias AD, Skarin AT, Leong T et al. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). Lung Cancer 1997; 17: 147-161.
24. Ichinose Y, Tsuchia R, Kato H Randomized trial of chemotherapy followed by surgery versus surgery for stage IIIA N2 non-small cell lung cancer: Thejapan clinical oncology group (lung cancer surgical study group) 9209. Lung Cancer 2000; 29: Suppl 2: 173.
25. Shepherd FA, Johnston MR, Payne D et al. Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group study. Br J Cancer 1998; 78: 683-685.
26. Le Chevalier T, Arriagada R, Tarayre M et al. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. Letter. J Natl Cancer Inst 1992; 84: 58.
27. Albain KS, Rusch VW, Crowley JJ et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995; 13: 1880-1892.
28. Burkes RL, Ginsberg RJ, Shepherd FA et al. Induction chemotherapy with mitomycin, vindesine and cisplatin for stage III unresectable non-small cell lung cancer: results of the Toronto phase II trial. J Clin Oncol 1992; 10: 580-586.
29. Chella A, Lucchi M, Ribechini A et al. Pre-operative chemotherapy for stage IIIa non-small cell lung cancer. Eur J Surg Oncol 1995; 21: 393-397.
30. Eberhardt W, Wilke H, Stamatis G et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial. J Clin Oncol 1998; 16: 622-634.
31. Finkelstein El, Urschel JD, Takita H Neoadjuvant chemotherapy for resectable non-small cell lung cancer. J Exp Clin Cancer Res 1997; 16: 437-439.
32. Kolek V, Grygárková I, Hajdúch M et al. Kombinace paklitaxel a karboplatina v neoadjuvantní chemoterapii u hraničně operabilních stádií IIIA nemalobuněçného karcinomu plic. Následná cílená pooperační adjuvantní chemoterapie. Stud Pneumol Phtiseol 2002; 62: 19-23.
33. Kolek V, Grygárková I, Hajdúch M et al. Neoadjuvantní chemoterapie u hraničně operabilních stádií IIIA nemalobuněčného karcinomu plic kombinací vinorelbin a karboplatina. Klinická Onkologie 2001; 14: 55-58.
34. Martini N, Kris MG, Flehinger BJ et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993; 55: 1365-1374.
35. Palackdharry CS, Durham SJ, Durzinskyd S et al. Premilinary results of neoadjuvant Paclitaxel and Carboplatin in the treatment of early stage non-small-cell lung cancer. Sem Oncol 1997; 24: S12-34-S12-36.
36. Pešek M, Brůha F, Mukenšnábl P Indukční předoperační chemoterapie plicní rakoviny. Prakt Lék 1998; 78: 253-255.
37. Rice TW, Adelstein DJ, Ciezki JP et al. Short-Course induction chemoradiotherapy with paclitaxel for stage III non-small cell lung cancer. Ann Thorac Surg 1998; 66: 1909-1914.
38. Van Zandwijk N, Smith EF, Kramer GW et al. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol 2000; 18: 2658-2664.
39. Betticher DC, Hsu Schmitz SF, Totsch M et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 2003; 21: 1752-1759.
40. O'Brien ME, Splinter T, Smit EF et al. Carboplatin and paclitaxel (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. An EORTC phase II study. Eur J Cancer 2003; 39: 1416-1422.
41. Cappuzzo F, Selvaggi G, Gregorc V et al. Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB non-small cell lung carcinoma: an Italian Lung Cancer Project Observational Study. Cancer 2003; 98: 128-134.
42. Voltolini L, Luzzi L, Ghiribelli C et al. Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy. Eur J Cardiothorac Surg 2001; 20: 1106-1112.
43. Špásová I, Hytych V, Petera J Účinnost a toxicita cisplatiny a vinorelbinu v léčbě III. stádia nemalobuněčné plicní rakoviny. Lék Zpr LF UK Hradec Králové 2000; 45: 103-111.
44. Špásová I, Petera J, Hytych V The Role of Neoadjuvant Chemotherapy in Marginally Resectable or Unresectable Stage III Non-Small Cell Lung Cancer. Neoplasma 2002; 49: 188-195.
45. Yang Ch, Tsai CM, Wang LS et al. Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer. Br J Cancer 2002; 86: 190-195.
46. Solomon B, Mitchell JD, Bunn PA Jr Adjuvant chemotherapy for resected non-small-cell lung cancer. Oncology (Williston Park) 2005; 19: 1685-1697, discussion 1698-1700, 1705.
47. Strauss GM, Herndon J, Maddaus MA et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633 (Abstract 7019). J Clin Oncol 2004; 22: Suppl 14S: 621.
48. Winton T, Livingston R, Johnson D et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. Report of National Cancer Institute of Canada Clinical Trials Group and National Cancer Institute of the United States Intergroup JBR.10. N. Engl J Med 2005; 352: 2589-2597.
49. Pisters K, Vallierres E, Bunn P et al. S9900: a phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (P/C) chemotherapy in early stage non-small cell lung cancer (NSCLC: preliminary results. Proc Am Soc Clin Oncol 2005; 24: A1095.
50. Scagliotti GV, Ch.E.S.T. Investigators. Preliminary results of Ch.E.S.T.: a phase III study of surgery alone or surgery plus preoperative gemcitabine-cisplatin in clinical early stages non-small cell lung cancer (NSCLC). J Clin Oncol 2005; 23: Suppl 16S: A7023.
51. Belani CP Adjuvant and neoadjuvant therapy in non-small cell lung cancer. Semin Oncol 2005; 32: Suppl 2: S9-S15.